BiotechTube

Essential oils + 0.2% chlorhexidine + Sterile water

ApprovedCompleted
1 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Oral Biofilm

Conditions

Oral Biofilm, Mouthwash, Periodontitis

Trial Timeline

Sep 1, 2012 → —

NCT ID
NCT02124655

About Essential oils + 0.2% chlorhexidine + Sterile water

Essential oils + 0.2% chlorhexidine + Sterile water is a approved stage product being developed by Johnson & Johnson for Oral Biofilm. The current trial status is completed. This product is registered under clinical trial identifier NCT02124655. Target conditions include Oral Biofilm, Mouthwash, Periodontitis.

What happened to similar drugs?

4 of 20 similar drugs in Oral Biofilm were approved

Approved (4) Terminated (2) Active (15)
✅AmifostineSun PharmaceuticalApproved
✅tramadol hydrochloride + acetaminophenJohnson & JohnsonApproved
✅Tranexamic Acid plus standard of carePfizerApproved
✅BivigamADMA BiologicsApproved
❌AL001 + Placebo + Open label - AL001AlectorPhase 3
🔄Micafungin + FluconazoleAstellas PharmaPhase 3
🔄micafungin + caspofunginAstellas PharmaPhase 3

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT02124655ApprovedCompleted

Competing Products

20 competing products in Oral Biofilm

See all competitors
ProductCompanyStageHype Score
AL001 + Placebo + Open label - AL001AlectorPhase 3
22
AL001AlectorPhase 2
25
AG013OragenicsPhase 2
17
LP-10 (Liposomal Tacrolimus)Lipella PharmaceuticalsPhase 2
29
Micafungin + FluconazoleAstellas PharmaPhase 3
40
micafungin + caspofunginAstellas PharmaPhase 3
40
Erlotinib + PlaceboAstellas PharmaPhase 3
40
AmifostineSun PharmaceuticalApproved
35
exenatide + Other antidiabetic therapiesEli LillyPre-clinical
26
Teriparatide 20 mcgEli LillyPhase 3
40
LY3884963 + Methylprednisolone + Optional Sirolimus + Optional PrednisoneEli LillyPhase 1/2
36
Baricitinib 4 milligram Oral TabletEli LillyPhase 2
39
tramadol hydrochloride + acetaminophenJohnson & JohnsonApproved
43
galantamine hydrobromideJohnson & JohnsonPhase 2
35
HR17031 injection + insulin glargineJiangsu Hengrui MedicinePhase 3
40
Camrelizumab + Camrelizumanb plus TPFJiangsu Hengrui MedicinePhase 2
35
Camrelizumab plus TP + TPJiangsu Hengrui MedicinePhase 3
47
AZD1981 + Neovletta 21/28 + Placebo AZD1981AstraZenecaPhase 1
29
DurvalumabAstraZenecaPhase 1/2
36
fostamatinib + Microgynon® 30 (Oral contraceptive) + PlaceboAstraZenecaPhase 1
29